AT397458T
Novel remedies for cancer
Abstract
Medicine-taking ammonia to soften to Singapore or wherein the pharmaceutically acceptable salt and active ingredients, for with the anti-HER2 antibody with medication therapy cancer treatment medicine.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
24 members in 13 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 2000228239 | Japan | A |
Members24
| Document | Office | Kind | |
|---|---|---|---|
| WO0209754A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7668901A | Australia | A | |
| CA2417255A1 | Canada | A1 | |
| KR20030019623A | Republic of Korea | A | |
| EP1308168A1 | European Patent Office (EPO) | A1 | |
| US2003157097A1 | United States of America | A1 | |
| CN1466464A | China | A | |
| EP1308168A4 | European Patent Office (EPO) | A4 | |
| US2008031881A1 | United States of America | A1 | |
| EP1308168B1 | European Patent Office (EPO) | B1 | |
| AT397458TThis record | Austria | T | |
| DE60134324D1 | Germany | D1 | |
| DK1308168T3 | Denmark | T3 | |
| US7449181B2 | United States of America | B2 | |
| ES2307633T3 | Spain | T3 | |
| TWI317285B | Taiwan Province of China | B | |
| CN100581585C | China | C | |
| CN101732333A | China | A | |
| US7879327B2 | United States of America | B2 | |
| US2011104160A1 | United States of America | A1 | |
| CA2417255C | Canada | C | |
| CN101732333B | China | B | |
| JP5117660B2 | Japan | B2 | |
| US9139658B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 1954360
Titles2
- German
- NEUE HEILMITTEL FÜR KREBS
- English
- NEW REMEDIES FOR CANCER
Classification
- CPC, 9
- C07K16/32
- A61K39/395
- A61K31/7036
- A61K39/39558
- A61K2039/505
- A61K2039/545
- A61P35/00
- A61P35/04
- A61P43/00
- IPC, 4
- A61K31 704
- A61K39 395
- A61P35 00
- C07K16 32